The present study examined if inter-individual factors moderated treatment responses in individuals experiencing early-stage psychosis who utilized the blended-care intervention ACT-DL55. We found that none of the moderators we examined negatively affected the effect of ACT-DL on clinical outcomes, meaning that ACT-DL may be an appropriate intervention for a wide range of individuals with early psychosis. While ACT-DL was generally effective, some moderators significantly influenced the improvement rate, with the most reliable effects for education and personality traits.
For demographics, individuals with a higher educational background consistently showed more significant improvement in global functioning than those with a lower educational background over time. This partially confirms our hypothesis that individuals with higher education would benefit more from ACT-DL. Possible explanations for this effect are that individuals with high education show more engagement with therapy 56,57 and tend to be more 'tech-savvy' 18. Higher technological literacy might have affected how individuals used ACT-DL, resulting in a possible dose effect. Earlier findings by Batink et al. (2016) strengthen this idea; they found a weak association between the dose of ACT-DL and clinical outcomes (including psychological flexibility), where the dose was defined as the self-reported number of executed exercises during the ACT-DL and time spent on those exercises 33. Our exploratory analyses showed that ACT-DL generally works equally well for males and females and that age did not significantly affect improvement rates.
For personality traits, our results revealed that both extraversion and neuroticism impacted responses to ACT-DL, albeit not always in keeping with our hypotheses. Consistent with our expectations, individuals with higher trait extraversion initially experienced a more rapid enhancement in their global functioning. However, at 12-month follow-up, higher and lower trait extraversion individuals converged to similar levels of global functioning. Contrary to our expectations, we found that individuals with lower trait extraversion and higher trait neuroticism significantly improved negative symptoms and psychological flexibility. The pattern of results showed a steady decline in negative symptoms for individuals with low trait extraversion and high trait neuroticism over time, alongside a steady increase in psychological flexibility, whereas the comparison groups exhibited stable symptom levels from baseline to 12-month follow-up. These effects could be explained by the possibility that individuals with lower extraversion or higher neuroticism begin treatment with more severe symptoms and lower psychological skills, allowing them more room for growth. Prior research supports this idea, linking lower extraversion to decreased social skills and higher neuroticism to more severe negative symptoms27,58. A potential regression to the mean due to a broader margin for improvement could offer one explanation for these observations.
Additionally, it is worth considering that individuals with high trait neuroticism, defined by heightened attention to criticism, feelings of inadequacy, and a perceived lack of control, might experience greater benefits from ACT-DL. This is because ACT emphasizes accepting negative emotions and enhancing values-based behaviors, directly addressing these vulnerabilities 59. Importantly, we found evidence that childhood trauma did not have any moderating effects on clinical outcomes, proving ACT-DL to be a safe and effective treatment for individuals with a history of childhood trauma.
Our study opens multiple avenues for future research. Given that only 59% of our participants completed the full intervention 12, methods to boost therapy engagement are pivotal to maximizing clinical outcomes. One possible solution is to provide personalized feedback on an individual's ecological-momentary-assessment data (EMA) in an interactive way. For example, embedding an overview page within the app that provides weekly statistics on the user's EMA data and ACT-exercises might increase engagement with the intervention. Prior research supports this idea and found that personalized feedback is a strong motivator for using EMA tools and enhances uptake and adherence without altering the intervention's core principles 60–62). Another solution is to enhance ACT-DL's efficacy at the individual level. Bacon et al. (2014) conducted qualitative research in which participants identified the distinct benefits of various ACT components. Mindfulness and Defusion, Acceptance, and Values were linked to stress reduction, providing life direction and meaning, and mitigating distress from unwanted private events, respectively. These findings suggest that different ACT components uniquely impact distinct facets of an individual's mental health. Future research should explore whether specific ACT-DL components distinctly influence particular symptoms or psychological processes. Such understanding would allow therapists to tailor the ACT-DL intervention to the individual's unique problem areas (e.g., psychotic distress). While our study provides valuable insights into the effects of moderators on treatment outcomes, several limitations warrant consideration. First, this study aimed to determine if specific moderators affected treatment outcomes in individuals who received ACT-DL. To maintain sufficient power for our confirmatory hypotheses, we narrowed our analysis exclusively to the ACT-DL group, refraining from comparisons with a control group. For a more definitive attribution of the observed changes to the intervention, future controlled studies conducted on larger samples are essential to validate our findings. Second, our sample comprised both FEP and UHR participants. While both categories signify early psychosis and are temporally and phenomenologically continuous, they represent different illness stages. Given that individuals with FEP had symptoms that reached the criteria for formal diagnosis and UHR did not, it is possible that both groups responded differently to ACT-DL. However, subgroup analysis in the primary study revealed no discernible differences between the UHR and FEP groups, and due to the study's randomization 11,12, these and other potential confounding variables were evenly distributed across conditions. Third, throughout the treatment period, which includes the six- and 12-month follow-ups, FEP individuals may have been prescribed antipsychotics if deemed clinically necessary. While this was also true for the control condition, and even though we observed significant differences in treatment outcomes between the ACT-DL and control groups 12, it remains unknown whether the longer-term effects identified in this study can be attributed exclusively to the ACT-DL intervention. In conclusion, this study highlights the importance of inter-individual factors as moderators of ACT-DL on clinical outcomes. Responses to ACT-DL were generally promising.
These limitations notwithstanding, this study highlights the importance of inter-individual factors as moderators of ACT-DL on clinical outcomes. We found evidence that education level, neuroticism, and extraversion predicted improvement rates of ACT-DL in individuals with early psychosis. Future research should replicate these findings in more extensive and diverse samples and explore strategies to enhance the effectiveness of ACT-DL for a broader range of individuals.